SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028506
Filing Date
2021-11-15
Accepted
2021-11-15 15:00:37
Documents
56
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 719679
2 ex10-1.htm EX-10.1 120213
3 ex31-1.htm EX-31.1 17280
4 ex31-2.htm EX-31.2 17191
5 ex32.htm EX-32 14301
6 form10q_001.jpg GRAPHIC 100788
7 ex10-1_001.jpg GRAPHIC 6244
8 ex10-1_002.jpg GRAPHIC 6169
  Complete submission text file 0001493152-21-028506.txt   4179512

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE abeo-20210930.xsd EX-101.SCH 27321
10 XBRL CALCULATION FILE abeo-20210930_cal.xml EX-101.CAL 54237
11 XBRL DEFINITION FILE abeo-20210930_def.xml EX-101.DEF 101619
12 XBRL LABEL FILE abeo-20210930_lab.xml EX-101.LAB 247491
13 XBRL PRESENTATION FILE abeo-20210930_pre.xml EX-101.PRE 200362
14 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 559329
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 211409459
SIC: 2834 Pharmaceutical Preparations